<DOC>
	<DOCNO>NCT02208024</DOCNO>
	<brief_summary>The purpose study test safety focus radiation ( Stereotactic Body Radiation Therapy , SBRT ) patient pancreatic cancer remove surgically .</brief_summary>
	<brief_title>Neoadjuvant Stereotactic Body Radiation Therapy Resectable Adenocarcinoma Pancreatic Head and/or Body</brief_title>
	<detailed_description />
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<criteria>Age &gt; 18 year . Histologically confirm pancreatic adenocarcinoma head and/or body ; least majority histopathologic specimen must identify adenocarcinoma . Pancreatic tumor must consider resectable time treatment planning . Definition resectable : metastasis , less 180 degree involvement superior mesenteric vein portal vein , involvement hepatic artery , superior mesenteric artery celiac artery No active infection require hospitalization Adequate labs Life expectancy &gt; 3 month . Patient receive chemotherapy prior enrollment . This typically consist 34 cycle chemotherapy . Patients 2 week break last chemotherapy administration start SBRT . Presence metastatic disease . Infections require systemic antibiotic treatment .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>